Filing Details
- Accession Number:
- 0001209191-21-070605
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-20 17:20:57
- Reporting Period:
- 2021-12-20
- Accepted Time:
- 2021-12-20 17:20:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1442145 | Verisk Analytics Inc. | VRSK | Services-Computer Processing & Data Preparation (7374) | 262994223 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472710 | V Mark Anquillare | C/O Verisk Analytics, Inc. 545 Washington Boulevard Jersey City NJ 07310 | Group President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-20 | 20,480 | $61.14 | 41,982 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-20 | 300 | $214.71 | 41,682 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-20 | 400 | $216.02 | 41,282 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-20 | 4,600 | $216.82 | 36,682 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-20 | 7,968 | $217.98 | 28,714 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-20 | 7,212 | $219.18 | 21,502 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-12-20 | 20,480 | $0.00 | 20,480 | $61.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 57,000 | Indirect | By Trust |
| Common Stock | 9,027 | Indirect | By Trust |
Footnotes
- These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
- These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
- These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
- These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4).
- These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5).
- These shares of common stock are held by the Mark Anquillare Spousal Living Trust.
- These shares of common stock are held in a Revocable Trust.
- This stock option was granted under the Issuer's 2009 Equity Incentive Plan.
- Immediately.
Billionaire Hedge Funds
